Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Sampo – H1 2025 Result Presentation and Q&A Session

By HC Andersen Capital
06.08.2025, 14.30
Sampo

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit your questions for the event.

The Nordic insurance company Sampo will publish its Half-Year Financial Report for 2025 on August 6, 2025. Later the same day, we will host a live online event with Sampo’s Head of Investor Relations, Sami Taipalus, at 14.30 CET. The event will include a brief presentation of the results and Sampo’s outlook for 2025 followed by a Q&A session.

The second quarter follows a very strong first quarter with insurance revenue increasing by 8% driven by both the UK and Nordic regions. Sampo also raised its synergy estimate for Topdanmark from EUR 95 million to EUR 140 million — a strong sign so early in the process — and even indicated that additional synergies may still be discovered along the way.

Following a favorable outcome on weather claims and increased Topdanmark synergies, the 2025 outlook was upgraded in connection with the Q1 2025 report. For 2025 Sampo expects group insurance revenue to be between EUR 8.8 billion and EUR 9.1 billion (5–9% growth) and a group underwriting result of EUR 1,400 million to EUR 1,500 million (6–14% growth).

Disclaimer: HC Andersen Capital receives payment from Sampo for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 09.18, 8 July 2025.

Sampo

9.91 EUR06.08.2025, 18.00
9.80 EUR
Target price
Accumulate
Recommendation updated:07.05

Recent videos

In
Incap India’s production and testing director interviewed
14.11.2025, 15.10 Incap
AKTIER MED FRIIS - UGE 46 2025
14.11.2025, 12.00
NI
NIBE, Audiocast, Q3'25
14.11.2025, 11.00 Nibe Industrier
ET
Egetis Therapeutics, Audiocast, 2025
14.11.2025, 10.00 Egetis Therapeutics
NN
HCA Morgenbørs 14/11 - Overvejende negative markeder og fokus på Bavarian Nordic
14.11.2025, 09.26 Novo Nordisk
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.